Abstract:Studies analyzing human cancer genome sequences and genetically modified mouse models have extensively expanded our understanding of human tumorigenesis, even challenging or reversing the dogma of certain genes as originally characterized by in vitro studies. Inhibitor-κB kinase α (IKKα), which is encoded by the conserved helix-loop-helix ubiquitous kinase (CHUK) gene, is first identified as a serine/threonine protein kinase in the inhibitor-κB kinase complex (IKK), which is composed of IKKα, IKKβ, and IKKγ (NEMO). IKK phosphorylates serine residues 32 and 36 of IκBα, a nuclear factor-κB (NF-κB) inhibitor, to induce IκBα protein degradation, resulting in the nuclear translocation of NF-κB dimers that function as transcriptional factors to regulate immunity, infection, lymphoid organ/cell development, cell death/growth, and tumorigenesis. NF-κB and IKK are broadly and differentially expressed in the cells of our body. For a long time, the idea that the IKK complex acts as a direct upstream activator of NF-κB in carcinogenesis has been predominately accepted in the field. Surprisingly, IKKα has emerged as a novel suppressor for skin, lung, esophageal, and nasopharyngeal squamous cell carcinoma, as well as lung and pancreatic adenocarcinoma (ADC). Thus, Ikkα loss is a tumor driver in mice. On the other hand, lacking the RANKL/RANK/IKKα pathway impairs mammary gland development and attenuates oncogene- and chemical carcinogen-induced breast and prostate tumorigenesis and metastasis. In general, NF-κB activation leads one of the major inflammatory pathways and stimulates tumorigenesis. Since IKKα and NF-κB play significant roles in human health, revealing the interplay between them greatly benefits the diagnosis, treatment, and prevention of human cancer. In this review, we discuss the intriguing attribution of NF-κB to CHUK/IKKα-involved carcinogenesis.

NF-κB、Tumorigenesis and Drug Development

NF‐κB signaling in inflammation and cancer

NF-κB in biology and targeted therapy: new insights and translational implications

Role of IKK-NFκB Signaling Pathway in Inflammation and Tumorigenesis

Role and Mechanisms of the NF-ĸB Signaling Pathway in Various Developmental Processes

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study

Nf-Kappa B and Its Regulation on the Immune System

Versatile function of NF-ĸB in inflammation and cancer

NF-κB, inflammation, immunity and cancer: coming of age

Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis

NF-κB signaling in inflammation

Inflammation meets cancer, with NF-κB as the matchmaker

Phosphorylation of the Regulators, a Complex Facet of NF-κB Signaling in Cancer

NF-κB Signaling and Cell-Fate Decision Induced by a Fast-Dissociating Tumor Necrosis Factor Mutant.

Signaling via the NFκB system

Positive and negative signaling components involved in TNF±-induced NF-ºB activation

The complexity of NF-κB signaling in inflammation and cancer

Roles of the NF-κB Pathway in B-Lymphocyte Biology

Life, death, and autophagy in cancer: NF-κB turns up everywhere

Nuclear Factor of Activated T Cells in Cancer Development and Treatment.

The Regulation of NF-κB Subunits by Phosphorylation